These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30647049)

  • 1. Evaluation of instructions in patient information leaflets for the use of intranasal corticosteroid sprays: an observational study.
    Rollema C; van Roon EM; Schilder AG; de Vries TW
    BMJ Open; 2019 Jan; 9(1):e026710. PubMed ID: 30647049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inadequate quality of administration of intranasal corticosteroid sprays.
    Rollema C; van Roon EN; de Vries TW
    J Asthma Allergy; 2019; 12():91-94. PubMed ID: 31040706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation.
    Gillies K; Huang W; Skea Z; Brehaut J; Cotton S
    Trials; 2014 Feb; 15():62. PubMed ID: 24548781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient information leaflets for antidepressants: are patients getting the information they need?
    Haw C; Stubbs J
    J Affect Disord; 2011 Jan; 128(1-2):165-70. PubMed ID: 20656359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observational study of administering intranasal steroid sprays by healthcare workers.
    de Boer M; Rollema C; van Roon E; Vries T
    BMJ Open; 2020 Aug; 10(8):e037660. PubMed ID: 32868363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
    Lohia S; Schlosser RJ; Soler ZM
    Allergy; 2013; 68(5):569-79. PubMed ID: 23590215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient information leaflets and package inserts of ibuprofen provided in the UK and Thailand: a comparative assessment.
    Nualdaisri P; Corlett SA; Krska J
    Int J Pharm Pract; 2024 May; 32(3):208-215. PubMed ID: 38442896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of animated cartoon-aided teaching of intranasal corticosteroid administration technique among Thai children with allergic rhinitis.
    Indradat S; Jirapongsananuruk O; Visitsunthorn N
    Asian Pac J Allergy Immunol; 2014 Jun; 32(2):166-70. PubMed ID: 25003731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient information leaflets--helpful guidance or a source of confusion?
    Bjerrum L; Foged A
    Pharmacoepidemiol Drug Saf; 2003; 12(1):55-9. PubMed ID: 12616848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial intelligence-generated patient information leaflets: a comparison of contents according to British Association of Dermatologists standards.
    Verran C
    Clin Exp Dermatol; 2024 Jun; 49(7):711-714. PubMed ID: 38169318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When describing harms and benefits to potential trial participants, participant information leaflets are inadequate.
    Cuddihy L; Howick J; Murphy E; Shiely F
    Trials; 2024 May; 25(1):292. PubMed ID: 38693579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal antihistamine is superior to oral H
    Du K; Qing H; Zheng M; Wang X; Zhang L
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):589-596.e3. PubMed ID: 32650045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics.
    Albassam A; Hughes DA
    Eur J Clin Pharmacol; 2021 Feb; 77(2):251-260. PubMed ID: 32989529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using alternative methodologies for evaluating patient medication leaflets.
    Krass I; Svarstad BL; Bultman D
    Patient Educ Couns; 2002 May; 47(1):29-35. PubMed ID: 12023098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention strategies are routinely communicated to potential trial participants but often differ from what was planned in the trial protocol: an analysis of adult participant information leaflets and their corresponding protocols.
    Murphy E; Gillies K; Shiely F
    Trials; 2024 Jun; 25(1):372. PubMed ID: 38858790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Side Effect Risk Communication in Patient Information Leaflets over the Past Decade: Results of a Survey.
    Harris K; Dickinson R; Raynor DK; MacDonald J; Knapp P
    Drug Saf; 2015 Aug; 38(8):721-7. PubMed ID: 26100144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Australian dermatological postoperative patient information leaflets: Should we have a national checklist?
    Hunt WT; O'Sullivan NA; Donnelly A
    Australas J Dermatol; 2018 May; 59(2):118-123. PubMed ID: 28425573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the data on pregnancy and lactation provided by patient information leaflets of anti-rheumatic drugs in Argentina.
    Sabando MO; Saavedra MA; Sequeira G; Kerzberg E
    Rheumatol Int; 2018 Apr; 38(4):669-673. PubMed ID: 29332199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal Corticosteroid Therapy: Systematic Review and Meta-analysis of Reported Safety and Adverse Effects in Adults.
    Donaldson AM; Choby G; Kim DH; Marks LA; Lal D
    Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1097-1108. PubMed ID: 32539494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of intranasal corticosteroid sprays during pregnancy: an updated review.
    Alhussien AH; Alhedaithy RA; Alsaleh SA
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):325-333. PubMed ID: 29164323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.